Medication info
Glipha Tablet (Glimepiride)

Glipha Tablet (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
Green oblong tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200401494 · Notified 2004.06.26 · Insurance code 657300060

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 glass of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic agent. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral glucose-lowering agent to this medicine There is no exact dose equivalence between this medicine and other oral glucose-lowering agents. When switching from another oral glucose-lowering agent to this medicine, it is recommended to follow the instructions given under Initial dose. That is, initiate treatment at 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medicine should be taken into account. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be monitored closely. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant use of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with dietary changes and exercise to help control blood sugar in patients with Type 2 diabetes. It can be used as monotherapy, and if blood glucose control is inadequate, it can be combined with oral hypoglycemics or insulin as needed. In particular, when control is difficult with sulfonylureas or metformin monotherapy, this medication can be combined with metformin to enhance therapeutic effect. This effectively improves blood glucose levels.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 glass of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic agent. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral glucose-lowering agent to this medicine There is no exact dose equivalence between this medicine and other oral glucose-lowering agents. When switching from another oral glucose-lowering agent to this medicine, it is recommended to follow the instructions given under Initial dose. That is, initiate treatment at 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medicine should be taken into account. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be monitored closely. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant use of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used for patients with insulin-dependent diabetes or diabetic ketoacidosis. Additionally, patients with hypersensitivity to this medication or its components, or to sulfonylureas should avoid its use. There is no experience using this medication in patients with severe liver or kidney impairment, and in such cases it is recommended to switch to insulin therapy. It is also safer for pregnant women or women who may become pregnant, as well as breastfeeding mothers, to avoid taking this medication. Patients with severe infections, or those before and after surgery, or patients with severe trauma should also consider insulin therapy. Patients with gastrointestinal disturbances like diarrhea or vomiting should be cautious as food absorption may be impaired, increasing the risk of hypoglycemia. During the first week of administration, the risk of hypoglycemia is high, so blood glucose levels must be monitored closely. Especially for elderly patients, those with poor nutrition or irregular eating habits, and those with imbalanced exercise and carbohydrate intake, extra caution is needed. Changing eating patterns or consuming alcohol may also increase the risk of hypoglycemia. Patients with compromised renal or liver function, those who overdose on this medication, or those with endocrine diseases such as thyroid disorders or adrenal insufficiency should also exercise caution. Additionally, elderly patients or those taking other medications may experience significant blood glucose variability, so management should be done in consultation with a physician. This medication contains Yellow No. 5, and patients with allergies or hypersensitivity to this component should use it cautiously. The most common side effect of this medication is hypoglycemia due to excessive lowering of blood sugar. If hypoglycemia occurs, symptoms may include headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and in severe cases, loss of consciousness or coma. Upon experiencing hypoglycemic symptoms, immediate intake of sugary food or seeking medical assistance is necessary. Temporary blurred vision or control issues may occur, and gastrointestinal symptoms such as nausea, vomiting, abdominal pain, or diarrhea may rarely occur. There are also rare reports of liver dysfunction, changes in blood cell count, and allergic reactions, so any unusual symptoms should be immediately reported to a doctor. While taking this medication, regular meals and exercise, as well as weight management, are important, and blood glucose control should be regularly checked. Both patients and their families should have a good understanding of hypoglycemia symptoms and risks, and it is advisable to always carry sugar with them if needed. When taken with other medications, the effectiveness of this medication may change, so all medications being taken should be reported to a healthcare provider. In particular, there may be interactions with specific antibiotics, antifungals, beta-blockers, and steroids. It is recommended that pregnant or breastfeeding women avoid using this medication due to potential harm to the fetus or newborn. For children under 18 years of age, the safety and efficacy are not established, so use should be avoided. Elderly patients may have reduced renal function, so the dosage of this medication should be adjusted and administered carefully. In case of overdose, hypoglycemia may worsen, so immediate medical treatment is required, and emergency treatments such as inducing vomiting, gastric lavage, or glucose injection may be necessary. This medication should be stored out of reach of children, and kept in its original container to prevent degradation or misuse.

Side effects

  • Hypoglycemia
  • headache
  • severe hunger
  • nausea
  • vomiting
  • fatigue
  • sleep
  • sleep disturbances
  • anxiety
  • aggression
Show 67 more
  • decreased concentration
  • decreased agility or motivation
  • depression
  • confusion
  • speech issues
  • aphasia
  • visual impairment
  • tremors
  • partial paralysis
  • sensory disturbances
  • dizziness
  • weakness
  • loss of self-control
  • temporary mental confusion
  • seizures
  • drowsiness
  • loss of consciousness
  • coma
  • shallow breathing
  • bradycardia
  • sweating
  • cold and clammy skin
  • tachycardia
  • hypertension
  • palpitations
  • angina
  • deep vein thrombosis
  • blurred vision
  • fullness in the upper abdomen
  • pressure
  • abdominal pain
  • diarrhea
  • increased liver enzymes
  • liver dysfunction
  • bile secretion disorders
  • jaundice
  • hepatitis
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • erythrocytopenia
  • agranulocytosis
  • pancytopenia
  • itching
  • hives
  • rash
  • shortness of breath
  • hypotension
  • shock
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • allergic vasculitis
  • photosensitivity reactions of the skin
  • decreased serum sodium concentration
  • taste disorders
  • hair loss
  • weight gain
  • dizziness
  • liver dysfunction
  • abdominal pain
  • arthralgia
  • dyspepsia
  • facial swelling
  • erectile dysfunction
  • flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Maintaining a storage temperature between 1 degree and 30 degrees Celsius is important. This helps preserve the medication's efficacy and safety for a long time.

Appearance and packaging

Appearance

Green oblong tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.